The best ingredients for hyperpigmentation — what the evidence shows.

Hyperpigmentation is one of the most searched skincare concerns, and one of the most commercially exploited. Dozens of ingredients are marketed as brightening or pigmentation-correcting with varying degrees of evidence behind them. The clinical picture is cleaner than the marketing: a small number of topical ingredients have genuine evidence for reducing melanin in the skin, and the most important intervention — daily SPF — is rarely the one that gets the attention.

What hyperpigmentation is

Hyperpigmentation refers to areas of skin that are darker than the surrounding tissue, caused by an excess of melanin in that area. There are several distinct types:

Post-inflammatory hyperpigmentation (PIH) is discolouration left after inflammation — acne, eczema, a cut, or any injury that triggers melanin production as part of the healing response. It is the most common type and the one most likely to respond to topical treatment.

Melasma is a hormonal-driven pigmentation that typically appears on the cheeks, forehead, and upper lip. It is associated with oestrogen and is commonly triggered or worsened by sun exposure, pregnancy, and hormonal contraception. It is the most treatment-resistant common type of hyperpigmentation because the trigger (hormonal influence on melanocytes) is internal.

Solar lentigines (sunspots, age spots) are discrete, flat, darkened patches resulting from cumulative UV exposure. They appear most often on areas of chronic sun exposure — the hands, forearms, face, and décolletage — and are most responsive to both topical treatment and procedural interventions.

The mechanism

Most topical hyperpigmentation treatments work by inhibiting tyrosinase, the enzyme that catalyses the conversion of tyrosine to melanin. Reducing tyrosinase activity slows new melanin production in treated areas. A smaller number of ingredients work by dispersing existing melanin granules, preventing their transfer to surrounding cells, or accelerating cell turnover to shed melanin-rich cells faster.

The reason hyperpigmentation is slow to fade with topical treatment is that melanin is physically present in the skin and must be shed through the natural cell cycle — a process that takes four to eight weeks in healthy skin, longer in older or sun-damaged skin.

SPF: the non-negotiable foundation

The most important intervention for any form of hyperpigmentation is daily broad-spectrum SPF. UV exposure is the single greatest driver of melanin production. Without consistent daily SPF, every other intervention is working against an active stimulus. Hyperpigmentation treatments applied without SPF show significantly reduced outcomes in comparative studies. This is not a marketing note — it is the mechanistic reason the combination works and the ingredient alone does not.

Daily SPF 30 or higher, applied as the final AM step, is the prerequisite for every treatment protocol below.

Vitamin C (L-ascorbic acid)

Vitamin C is the most studied topical ingredient for hyperpigmentation. At concentrations of 10%–20%, it inhibits tyrosinase, reduces melanin transfer between melanocytes and keratinocytes, and provides antioxidant protection against UV-induced melanogenesis. The evidence for PIH and solar lentigines is strong; the evidence for melasma is moderate (melasma is hormonally driven and less responsive to tyrosinase inhibition alone).

Applied in the morning under SPF, vitamin C addresses both the direct cause (tyrosinase activity) and a major ongoing trigger (UV-generated oxidative stress). This is the most practical reason to use vitamin C as the primary treatment ingredient for most forms of hyperpigmentation — it treats the pigment and protects against further stimulus in a single step.

Niacinamide

Niacinamide (vitamin B3) works through a different mechanism than tyrosinase inhibitors. It reduces the transfer of melanosomes — the vesicles that carry melanin — from melanocytes to surrounding keratinocytes. Rather than preventing melanin production, it limits how much reaches the skin surface. At concentrations of 4%–5%, it produces measurable brightening with a very low risk of irritation, making it the most broadly tolerable brightening ingredient available. It is compatible with most actives and can be used morning or evening.

Azelaic acid

Azelaic acid is a dicarboxylic acid derived from grains. At concentrations of 15%–20% (prescription strength) or 10% (over-the-counter), it inhibits tyrosinase and has a particular affinity for hyperactive melanocytes — the cells responsible for producing excess melanin — while leaving normal melanocytes relatively unaffected. This selective action makes it especially useful for PIH and melasma. It is also anti-inflammatory, which addresses the underlying inflammation that drives PIH in the first place. It is well-tolerated by most skin types including sensitive skin, though it can cause mild stinging on initial application.

Alpha-arbutin

Alpha-arbutin is a derivative of hydroquinone that releases hydroquinone slowly within the skin, inhibiting tyrosinase with fewer of the stability and irritation concerns associated with hydroquinone itself. At 1%–2%, it produces meaningful brightening. The clinical evidence base is smaller than for vitamin C or azelaic acid, but it is a stable, well-tolerated ingredient with a clean safety profile for long-term use.

Tranexamic acid

Tranexamic acid is a relatively newer addition to hyperpigmentation protocols with emerging evidence. It inhibits plasminogen, which interrupts the signalling pathway between UV exposure and melanin production. It is particularly studied for melasma, where evidence shows comparable efficacy to conventional treatments with fewer side effects. At concentrations of 2%–5% in topical formulations, it is well-tolerated and can be used alongside other actives.

Kojic acid

Kojic acid inhibits tyrosinase by chelating the copper ions the enzyme requires to function. It has a good evidence base for brightening but is less stable than alpha-arbutin — it oxidises and turns pink/brown on exposure to air and light — which limits its use in some formulations. At 1%–4%, it produces measurable results but can cause irritation in sensitive skin at higher concentrations.

What does not have meaningful evidence

A long list of botanical extracts appear in brightening formulations with claims unsupported by controlled clinical trials: licorice extract, turmeric, bearberry, mulberry. They may have mild antioxidant activity, and some contain compounds with theoretical tyrosinase-inhibiting properties at concentrations higher than what appears in cosmetic formulations. They are not reliable treatment ingredients for established hyperpigmentation.

Physical exfoliants (scrubs, brushes) shed melanin-containing cells and can temporarily improve the appearance of hyperpigmentation, but they do not address the mechanism. Without topical treatment to slow new melanin production, the pigment returns with the next cell cycle.

The practical approach

A structured approach to hyperpigmentation:

Foundation: daily broad-spectrum SPF 30+, applied every morning, consistently.

Primary treatment: vitamin C serum in the AM for most skin types; azelaic acid in the PM (or AM for sensitive skin that tolerates it); niacinamide as a supporting ingredient in either routine.

Targeted additions: alpha-arbutin or tranexamic acid for persistent melasma or PIH unresponsive to the above.

Timeline: visible improvement with consistent topical treatment typically takes eight to twelve weeks. Melasma is the exception — it is the most treatment-resistant common type and often requires combined topical and procedural approaches for significant improvement.

The temptation in treating hyperpigmentation is to add more ingredients. The more useful approach is to choose two or three that work through different mechanisms, use them consistently, and prioritise SPF — which prevents the recurrence that undoes treatment progress faster than any active can address it.